Analyst Price Targets — TDOC
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 30, 2026 2:12 pm | Brian Tanquilut | Jefferies | $8.00 | $6.72 | TheFly | Teladoc price target lowered to $8 from $9 at Jefferies |
| July 30, 2026 12:49 pm | — | Evercore ISI | $7.50 | $6.72 | TheFly | Teladoc price target lowered to $7.50 from $10 at Evercore ISI |
| July 21, 2026 10:54 am | Richard Close | Canaccord Genuity | $11.00 | $9.65 | TheFly | Teladoc price target raised to $11 from $10 at Canaccord |
| April 8, 2026 1:16 pm | — | Evercore ISI | $6.00 | $5.27 | TheFly | Teladoc price target raised to $6 from $5 at Evercore ISI |
| March 10, 2026 10:06 am | George Hill | Deutsche Bank | $11.00 | $5.58 | StreetInsider | Deutsche Bank Upgrades Teladoc (TDOC) to Buy |
| February 26, 2026 1:20 pm | David Grossman | Stifel Nicolaus | $6.00 | $5.07 | StreetInsider | Teladoc (TDOC) PT Lowered to $6 at Stifel Following Q4 Results |
| February 26, 2026 10:59 am | Stephen Baxter | Wells Fargo | $6.00 | $4.65 | StreetInsider | Teladoc (TDOC) PT Lowered to $6 at Wells Fargo |
| January 16, 2026 12:00 pm | — | Goldman Sachs | $8.00 | $6.53 | TheFly | Teladoc price target lowered to $8 from $9 at Goldman Sachs |
| January 9, 2026 10:52 am | David Roman | Goldman Sachs | $9.00 | $7.61 | TheFly | Teladoc price target lowered to $9 from $10 at Goldman Sachs |
| December 8, 2025 9:17 pm | — | Barclays | $8.50 | $7.56 | TheFly | Teladoc initiated with an Equal Weight at Barclays |
Latest News for TDOC
Teladoc Health's growth is supported by chronic care, international expansion and Teladoc One, but BetterHelp weakness and losses temper the outlook.
Connor Clark and Lunn Investment Management Ltd. bought a new position in Teladoc Health, Inc. (NYSE: TDOC) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 87,511 shares of the health services provider's stock, valued at approximately $742,000. Several other hedge funds
Teladoc Health said on Monday it appointed Michael Grasher as its chief financial officer, bringing in an industry veteran to help the virtual healthcare company navigate rising demand for its insurance-covered business.
Appointment brings seasoned financial leadership as Teladoc Health advances its strategy aimed at delivering disciplined, sustainable growth NEW YORK, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today announced the appointment of Michael Grasher as Chief Financial Officer, effective immediately. Mr. Grasher is an accomplished financial executive with more…
Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock?
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for TDOC.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.